BRENDAN LEE to Cost-Benefit Analysis
This is a "connection" page, showing publications BRENDAN LEE has written about Cost-Benefit Analysis.
Connection Strength
0.029
-
Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature. Genet Med. 2019 01; 21(1):3-16.
Score: 0.029